Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Nov;74(10):1605–1614. doi: 10.1038/bjc.1996.596

Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines.

C D Gerharz 1, B Hildebrandt 1, R Moll 1, U Ramp 1, M Sarbia 1, S Störkel 1, P Koldovsky 1, H E Gabbert 1
PMCID: PMC2074836  PMID: 8932342

Abstract

Chromophilic renal cell carcinoma is a distinct type of human renal cancer, only recently recognised and defined by its characteristic histomorphological aspect and cytogenetic aberrations. We are the first to report on the establishment and cytogenetic characterisation of a panel of four permanent cell lines, i.e. chromphi-1, -2, -3 and -4, derived from strictly defined renal cell carcinomas (RCCs) of the chromophilic type and kept in continuous culture for up to 5 years. Immunohistochemistry revealed coexpression of vimentin and cytokeratins in all cell lines the cytokeratin polypeptide patterns, however, varying between the different cell lines. By light and transmission electron microscopy, various amounts of cytoplasmatic glycogen deposition were observed, being most pronounced in chromphi-3 and -4. The mean population doubling time ranged from 24 h (chromphi-1) to 51 h (chromphi-4). Chromphi-1 tumour cells produced slowly growing tumours in nude mice using the subrenal capsule assay. In all cell lines, cytogenetic analysis revealed numerical chromosomal aberrations known to be characteristic for chromophilic RCCs, i.e. loss of the Y chromosome, tri- or tetrasomy of chromosomes 7 and 17 as well as various combinations of additional structural and numerical chromosomal aberrations. Karyological aberrations were least pronounced in chromphi-2 and most complex in chromphi-1. Chromosomal aberrations typically affecting the short arm of chromosome 3 in clear cell RCCs were not observed in any of our cell lines.

Full text

PDF
1605

Images in this article

1608Figure 1
on p.1608
1609Figure 2
on p.1609
1610Figure 3
on p.1610
1611Figure 4
on p.1611
1612Figure 5
on p.1612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anglard P., Trahan E., Liu S., Latif F., Merino M. J., Lerman M. I., Zbar B., Linehan W. M. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res. 1992 Jan 15;52(2):348–356. [PubMed] [Google Scholar]
  2. Carroll P. R., Murty V. V., Reuter V., Jhanwar S., Fair W. R., Whitmore W. F., Chaganti R. S. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet Cytogenet. 1987 Jun;26(2):253–259. doi: 10.1016/0165-4608(87)90059-8. [DOI] [PubMed] [Google Scholar]
  3. Dekernion J. B., Ramming K. P., Smith R. B. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol. 1978 Aug;120(2):148–152. doi: 10.1016/s0022-5347(17)57082-2. [DOI] [PubMed] [Google Scholar]
  4. Ebert T., Bander N. H., Finstad C. L., Ramsawak R. D., Old L. J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 1990 Sep 1;50(17):5531–5536. [PubMed] [Google Scholar]
  5. Emanuel A., Szucs S., Weier H. U., Kovacs G. Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer. 1992 Jan;4(1):75–77. doi: 10.1002/gcc.2870040110. [DOI] [PubMed] [Google Scholar]
  6. Engers R., Gerharz C. D., Moll R., Pohl A., Sarbia M., Gabbert H. E. Interclonal heterogeneity in a human epithelioid-sarcoma cell line (GRU-1). Int J Cancer. 1994 Nov 15;59(4):548–553. doi: 10.1002/ijc.2910590419. [DOI] [PubMed] [Google Scholar]
  7. Fingert H. J., Chen Z., Mizrahi N., Gajewski W. H., Bamberg M. P., Kradin R. L. Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay. Cancer Res. 1987 Jul 15;47(14):3824–3829. [PubMed] [Google Scholar]
  8. Gerharz C. D., Gabbert H. E., Engers R., Ramp U., Mayer H., Biesalski H. K., Luley C. Heterogeneous response to differentiation induction in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1). Cancer Res. 1989 Dec 15;49(24 Pt 1):7132–7140. [PubMed] [Google Scholar]
  9. Gerharz C. D., Moll R., Störkel S., Ramp U., Hildebrandt B., Molsberger G., Koldovsky P., Gabbert H. E. Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Am J Pathol. 1995 Apr;146(4):953–962. [PMC free article] [PubMed] [Google Scholar]
  10. Gerharz C. D., Moll R., Störkel S., Ramp U., Thoenes W., Gabbert H. E. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am J Pathol. 1993 Mar;142(3):851–859. [PMC free article] [PubMed] [Google Scholar]
  11. Gerharz C. D., Ramp U., Olert J., Moll R., Störkel S., Marx N., Gabbert H. E. Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type. Virchows Arch. 1994;424(4):403–409. doi: 10.1007/BF00190563. [DOI] [PubMed] [Google Scholar]
  12. Grossman H. B., Wedemeyer G., Ren L. Q. Human renal carcinoma: characterization of five new cell lines. J Surg Oncol. 1985 Mar;28(3):237–244. doi: 10.1002/jso.2930280320. [DOI] [PubMed] [Google Scholar]
  13. Hughson M. D., Johnson L. D., Silva F. G., Kovacs G. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. Mod Pathol. 1993 Jul;6(4):449–456. [PubMed] [Google Scholar]
  14. Höehn W., Schroeder F. H. Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65). Preliminary report. Invest Urol. 1978 Sep;16(2):106–112. [PubMed] [Google Scholar]
  15. Klein G. The role of gene dosage and genetic transpositions in carcinogenesis. Nature. 1981 Nov 26;294(5839):313–318. doi: 10.1038/294313a0. [DOI] [PubMed] [Google Scholar]
  16. Kovacs G., Erlandsson R., Boldog F., Ingvarsson S., Müller-Brechlin R., Klein G., Sümegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1571–1575. doi: 10.1073/pnas.85.5.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kovacs G., Fuzesi L., Emanual A., Kung H. F. Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer. 1991 Jul;3(4):249–255. doi: 10.1002/gcc.2870030403. [DOI] [PubMed] [Google Scholar]
  18. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res. 1993;62:89–124. doi: 10.1016/s0065-230x(08)60316-4. [DOI] [PubMed] [Google Scholar]
  19. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol. 1989 Jan;134(1):27–34. [PMC free article] [PubMed] [Google Scholar]
  20. Kovacs G., Tory K., Kovacs A. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences. J Pathol. 1994 May;173(1):39–44. doi: 10.1002/path.1711730107. [DOI] [PubMed] [Google Scholar]
  21. Maldazys J. D., deKernion J. B. Prognostic factors in metastatic renal carcinoma. J Urol. 1986 Aug;136(2):376–379. doi: 10.1016/s0022-5347(17)44873-7. [DOI] [PubMed] [Google Scholar]
  22. Matsuda M., Osafune M., Nakano E., Kotake T., Sonoda T., Watanabe S., Hada T., Okochi T., Higashino K., Yamamura Y. Characterization of an established cell line from human renal carcinoma. Cancer Res. 1979 Nov;39(11):4694–4699. [PubMed] [Google Scholar]
  23. Mayer D., Bannasch P. Activity of glycogen synthase and phosphorylase and glucose 6-phosphate content in renal clear cell carcinomas. J Cancer Res Clin Oncol. 1988;114(4):369–372. doi: 10.1007/BF02128180. [DOI] [PubMed] [Google Scholar]
  24. Moll R., Löwe A., Laufer J., Franke W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992 Feb;140(2):427–447. [PMC free article] [PubMed] [Google Scholar]
  25. Naito S., Kanamori T., Hisano S., Tanaka K., Momose S., Kamata N. Human renal cell carcinoma: establishment and characterization of two new cell lines. J Urol. 1982 Nov;128(5):1117–1121. doi: 10.1016/s0022-5347(17)53357-1. [DOI] [PubMed] [Google Scholar]
  26. Neves R. J., Zincke H., Taylor W. F. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival. J Urol. 1988 Jun;139(6):1173–1176. doi: 10.1016/s0022-5347(17)42851-5. [DOI] [PubMed] [Google Scholar]
  27. Pitz S., Moll R., Störkel S., Thoenes W. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest. 1987 Jun;56(6):642–653. [PubMed] [Google Scholar]
  28. Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971 Oct 30;2(7731):971–972. doi: 10.1016/s0140-6736(71)90287-x. [DOI] [PubMed] [Google Scholar]
  29. Steinberg P., Störkel S., Oesch F., Thoenes W. Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest. 1992 Oct;67(4):506–511. [PubMed] [Google Scholar]
  30. Störkel S., Steart P. V., Drenckhahn D., Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56(4):237–245. doi: 10.1007/BF02890022. [DOI] [PubMed] [Google Scholar]
  31. Sytkowski A. J., Richie J. P., Bicknell K. A. New human renal carcinoma cell line established from a patient with erythrocytosis. Cancer Res. 1983 Mar;43(3):1415–1419. [PubMed] [Google Scholar]
  32. Thoenes W., Störkel S., Rumpelt H. J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract. 1986 May;181(2):125–143. doi: 10.1016/S0344-0338(86)80001-2. [DOI] [PubMed] [Google Scholar]
  33. Thoenes W., Störkel S., Rumpelt H. J., Moll R., Baum H. P., Werner S. Chromophobe cell renal carcinoma and its variants--a report on 32 cases. J Pathol. 1988 Aug;155(4):277–287. doi: 10.1002/path.1711550402. [DOI] [PubMed] [Google Scholar]
  34. Vindeløv L. L., Christensen I. J., Nissen N. I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry. 1983 Mar;3(5):328–331. doi: 10.1002/cyto.990030504. [DOI] [PubMed] [Google Scholar]
  35. Yoshida M. A., Ohyashiki K., Ochi H., Gibas Z., Pontes J. E., Prout G. R., Jr, Huben R., Sandberg A. A. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res. 1986 Apr;46(4 Pt 2):2139–2147. [PubMed] [Google Scholar]
  36. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. 1987 Jun 25-Jul 1Nature. 327(6124):721–724. doi: 10.1038/327721a0. [DOI] [PubMed] [Google Scholar]
  37. Zbar B., Tory K., Merino M., Schmidt L., Glenn G., Choyke P., Walther M. M., Lerman M., Linehan W. M. Hereditary papillary renal cell carcinoma. J Urol. 1994 Mar;151(3):561–566. doi: 10.1016/s0022-5347(17)35015-2. [DOI] [PubMed] [Google Scholar]
  38. van den Berg E., van der Hout A. H., Oosterhuis J. W., Störkel S., Dijkhuizen T., Dam A., Zweers H. M., Mensink H. J., Buys C. H., de Jong B. Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer. 1993 Sep 9;55(2):223–227. doi: 10.1002/ijc.2910550210. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES